Literature DB >> 3830751

Mitosis in hepatocytes is generally associated with elevated levels of the target polypeptide of a liver carcinogen.

R P Custer, S Sorof.   

Abstract

Rat hepatocytes have previously been found to contain in their cytoplasm a 14,000-dalton polypeptide that: is markedly and specifically increased in concentration during the infrequent mitoses that occur in hepatocytes of adult normal liver; is apparently related to a 17,500-dalton polypeptide that is tightly bound to the chromatin of nuclei of normal adult liver; is the principal covalent target of the carcinogen, N-2-fluorenylacetamide (FAA; 2-acetylaminofluorene), early during liver carcinogenesis; is present at highly elevated levels in the proliferating hepatocytes of hyperplastic foci brought about by the two liver carcinogens, FAA and 3'-methyl-4-dimethylaminoazobenzene; and is present at a greatly depressed level in the mitotically nonresponsive parenchyma that surrounds these hyperplastic foci. In the present investigation, we examined the levels of the two polypeptides in hepatocytes undergoing cell division at different rates in livers of diverse normal and regenerative states. Using immunohistochemical techniques, both polypeptides were detected in developing hepatocytes in as early as 15- and 19-day rat fetuses. With the increasing maturity of fetal and neonatal livers in normal rats, a greater percentage of dividing hepatocytes exhibited a higher concentration of the 14,000-dalton target polypeptide than that seen in adjacent interphase hepatocytes. The percentage of mitotic hepatocytes with an elevated level of the polypeptide increased progressively with hepatic development as follows: 38% in 15-day fetuses, 50% in 19-day fetuses, 85% in 1-day neonates, between 79% and 93% until 28 days of age, and finally, 99% in normal adults.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3830751     DOI: 10.1111/j.1432-0436.1985.tb00529.x

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  7 in total

1.  Elevated FABP1 serum levels are associated with poorer survival in acetaminophen-induced acute liver failure.

Authors:  Constantine J Karvellas; Jaime L Speiser; Mélanie Tremblay; William M Lee; Christopher F Rose
Journal:  Hepatology       Date:  2017-01-19       Impact factor: 17.425

2.  Enhanced expression of cytosolic fatty acid binding protein and fatty acid uptake during liver regeneration in rats.

Authors:  GuQi Wang; Qing Ming Chen; Gerald Y Minuk; Yuewen Gong; Frank J Burczynski
Journal:  Mol Cell Biochem       Date:  2004-07       Impact factor: 3.396

3.  Liver fatty acid-binding protein: specific mediator of the mitogenesis induced by two classes of carcinogenic peroxisome proliferators.

Authors:  S H Khan; S Sorof
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

4.  Liver fatty acid binding protein is the mitosis-associated polypeptide target of a carcinogen in rat hepatocytes.

Authors:  J A Bassuk; P N Tsichlis; S Sorof
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

Review 5.  Modulation of mitogenesis by liver fatty acid binding protein.

Authors:  S Sorof
Journal:  Cancer Metastasis Rev       Date:  1994-12       Impact factor: 9.264

Review 6.  Recent insights into the biological functions of liver fatty acid binding protein 1.

Authors:  GuQi Wang; Herbert L Bonkovsky; Andrew de Lemos; Frank J Burczynski
Journal:  J Lipid Res       Date:  2015-10-06       Impact factor: 5.922

7.  Liver fatty acid binding protein expression in colorectal neoplasia.

Authors:  L C Lawrie; S R Dundas; S Curran; G I Murray
Journal:  Br J Cancer       Date:  2004-05-17       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.